References

1. Department of Health. United Kingdom Drug Situation. Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2011. Page last reviewed May 23.Download Now
2. Prenoxad Injection Summary of Product Characteristics. Page last reviewed May 23.Download Now
3. Sporer K A, and Kral A H Prescription naloxone: a novel approach to heroin overdose prevention http://escholarship.org/uc/item/2208307d. Annals of Emergency Medicine 2007;
   49 (2). Page last reviewed May 23.Download Now
4. Strang J, et al. Family carers and the prevention of heroin overdose deaths: Unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone. Drugs: education, prevention and policy 2008; 15 (2): 211–218. Page last reviewed May 23.Download Now
5. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take home naloxone. BMJ 1996; 312 (7044): 1435. Page last reviewed May 23.Download Now
6. Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability Addiction 1999; 94: 199–204. Page last reviewed May 23.Download Now